Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data
-
- Shun Kohsaka
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan;
-
- Tatsunori Murata
- Crecon Medical Assessment Inc., Tokyo, Japan;
-
- Naoko Izumi
- Pfizer Japan Inc., Tokyo, Japan;
-
- Jun Katada
- Pfizer Japan Inc., Tokyo, Japan;
-
- Feng Wang
- Bristol-Myers Squibb Co., NY, USA;
-
- Yasuo Terayama
- Department of Gerontology, School of Medicine, Iwate Medical University, Iwate, Japan
収録刊行物
-
- Current Medical Research and Opinion
-
Current Medical Research and Opinion 33 (11), 1955-1963, 2017-09-12
Informa UK Limited
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1360283692223378048
-
- ISSN
- 14734877
- 03007995
-
- データソース種別
-
- Crossref
- KAKEN